Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lactaid is a leading consumer healthcare brand specializing in products for individuals with lactose intolerance. Originally founded as an independent company by Alan Kligerman, it pioneered the use of the lactase enzyme to break down lactose in dairy products, making them digestible for those with lactase deficiency. The brand's portfolio includes dietary supplement caplets and drops, as well as a wide range of lactose-free dairy products such as milk, ice cream, and cottage cheese. Currently owned by Kenvue, the independent consumer health company spun off from Johnson & Johnson, Lactaid remains the most recognized name in the lactose-free dairy market. Its business model focuses on providing over-the-counter digestive aids and modified food products to manage metabolic enzyme deficiencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lactaid.